Bioera S.p.A. | Income Statement
Fiscal year is January-December. All values EUR Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
46,606.00
51,680.00
55,976.00
52,922.00
45,790.00
Cost of Goods Sold (COGS) incl. D&A
42,577.00
48,380.00
53,014.00
48,882.00
37,073.00
Gross Income
4,029.00
3,300.00
2,962.00
4,040.00
8,717.00
SG&A Expense
4,870.00
4,924.00
5,453.00
5,497.00
12,579.00
EBIT
1,686.00
2,216.00
2,798.00
2,159.00
4,795.00
Unusual Expense
226.00
1,925.00
656.00
16.00
805.00
Non Operating Income/Expense
2,113.00
1,058.00
1,551.00
899.00
683.00
Interest Expense
483.00
355.00
358.00
385.00
551.00
Pretax Income
269.00
3,355.00
2,251.00
1,608.00
5,454.00
Income Tax
314.00
1,214.00
1,456.00
997.00
831.00
Equity in Affiliates
-
10.00
3.00
133.00
479.00
Consolidated Net Income
583.00
2,151.00
3,704.00
2,738.00
6,764.00
Net Income
527.00
2,273.00
3,380.00
2,787.00
5,146.00
Net Income After Extraordinaries
1,178.00
2,273.00
3,380.00
2,787.00
5,146.00
Net Income Available to Common
675.00
2,273.00
3,380.00
2,787.00
5,146.00
EPS (Basic)
0.02
0.06
0.09
0.08
0.14
Basic Shares Outstanding
36,000.30
36,000.30
36,000.30
36,000.30
36,818.00
EPS (Diluted)
0.00
0.06
0.09
0.08
0.14
Diluted Shares Outstanding
36,000.30
36,000.30
36,000.30
36,000.30
36,818.00
EBITDA
1,274.00
1,637.00
2,132.00
1,466.00
3,964.00
Other Operating Expense
845.00
592.00
307.00
702.00
933.00
Non-Operating Interest Income
99.00
83.00
10.00
21.00
14.00
Minority Interest Expense
56.00
122.00
324.00
49.00
1,618.00
About Bioera
View Profile
